home / stock / vtrs / vtrs news


VTRS News and Press, Viatris Inc.

Stock Information

Company Name: Viatris Inc.
Stock Symbol: VTRS
Market: NASDAQ
Website: viatris.com

Menu

VTRS VTRS Quote VTRS Short VTRS News VTRS Articles VTRS Message Board
Get VTRS Alerts

News, Short Squeeze, Breakout and More Instantly...

VTRS - Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)

Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD) PR Newswire Addresses a Significant Unmet Need in Japan as First and Only Approved Treatment Option for GAD PITTSBURGH , March 23, 2026 /PRNewswire/...

VTRS - 24 Safer Buys From 10 Years Of Dogcatcher Digging

2026-03-22 12:26:27 ET Foreword Read the full article on Seeking Alpha For further details see: 24 Safer Buys From 10 Years Of Dogcatcher Digging

VTRS - Citi's top large-cap stocks with positive ROE trends

2026-03-22 09:54:14 ET More on Astoria US Equal Weight Quality Kings ETF Seeking Alpha’s Quant Rating on Astoria US Equal Weight Quality Kings ETF Dividend scorecard for Astoria US Equal Weight Quality Kings ETF Read the full article on Seeking Alpha F...

VTRS - Viatris: Is It A Credible Turnaround Or Overly Optimistic 2030 Plan?

2026-03-20 12:17:10 ET Thesis: Aggressive long-term targets As you know, Viatris Inc. ( VTRS ) has just outlined a pretty ambitious long-term strategy through to 2030. The aim is to transform its base business into a much more durable, higher-margin portfolio whilst still ma...

VTRS - Viatris sets long-term targets ahead of investor event

2026-03-19 09:11:37 ET More on Viatris Viatris Inc. (VTRS) Q4 2025 Earnings Call Transcript Viatris Inc. 2025 Q4 - Results - Earnings Call Presentation Viatris: Deep-Value Pharma With Emerging Growth Catalysts And Strong Cash Generation Generic drug suppliers...

VTRS - Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030

Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030 PR Newswire Growing Base Business Evolving Into More Durable Portfolio of Higher-Margin Generics, Value-Added Medicines and Established Brands Expecting Impactful Near-Term Launches, Includi...

VTRS - Generic drug suppliers could face pressure from Strait of Hormuz closure

2026-03-16 12:56:22 ET More on Viatris, Teva Pharmaceutical Teva: Shedding The Generics Skin To Reveal A Fairly Priced, Branded Powerhouse Teva Pharmaceutical Industries Limited (TEVA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Teva Phar...

VTRS - Catalyst Watch: Nvidia's GTC Conference, FOMC meeting, Okta event, and triple-witching day

2026-03-13 15:00:18 ET More on the markets Deja Vu--Spiking Oil Prices, Surging Credit Worries The 'New' Government Spending Picture Strait Of Hormuz: Buy The Fear Before This Waterway Clears Options market heavily hedged as volatility spikes, Susquehanna...

VTRS - Viatris resolves case over use of woman's cancer cells to advance drug research

2026-03-12 12:20:25 ET More on Viatris Viatris Inc. (VTRS) Q4 2025 Earnings Call Transcript Viatris Inc. 2025 Q4 - Results - Earnings Call Presentation Viatris: Deep-Value Pharma With Emerging Growth Catalysts And Strong Cash Generation GoodRx to offer up to ...

VTRS - GoodRx to offer up to 85% discount on Viatris drugs

2026-03-11 10:07:38 ET More on GoodRx Holdings, Viatris GoodRx: Losing Relevance With Consumers (Downgrade) Viatris Inc. (VTRS) Q4 2025 Earnings Call Transcript GoodRx Holdings, Inc. (GDRX) Q4 2025 Earnings Call Transcript Top 10 healthcare stocks with highes...

Next 10